NCT04892732View on ClinicalTrials.gov

Replication of the D58 Asthma Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

66,581

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

June 11, 2021

Study Completion Date

June 11, 2021

Conditions
Asthma
Interventions
DRUG

Budesonide

Budesonide dispensing claim is used as the reference group.

DRUG

Budesonide-Formoterol

Budesonide-Formoterol dispensing claim is used as the exposure group.

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04892732 - Replication of the D58 Asthma Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter